Quon, B.
298  results:
Search for persons X
?
1

477 Assessing the impact of elexacaftor-tezacaftor-ivacafto..:

Nguyen, M. ; Desai, S. ; Quon, B...
Journal of Cystic Fibrosis.  22 (2023)  - p. S250-S251 , 2023
 
?
 
?
 
?
4

709 Randomized, double-blind, placebo-controlled trial of o..:

Waters, V. ; Shaw, M. ; Quon, B....
Journal of Cystic Fibrosis.  22 (2023)  - p. S392 , 2023
 
?
5

383 Socioeconomic impact of cystic fibrosis in Canada:

Stanojevic, S. ; Rabin, H. ; Cheng, S....
Journal of Cystic Fibrosis.  22 (2023)  - p. S194 , 2023
 
?
 
?
 
?
8

185 Long-term safety and efficacy of elexacaftor/tezacaftor..:

Chmiel, J. ; Barry, P.J. ; Colombo, C....
Journal of Cystic Fibrosis.  21 (2022)  - p. S108-S109 , 2022
 
?
 
?
10

433: Rationale and design of an international multicenter p..:

Hernandez, R. ; Cogen, J. ; Blanchard, A....
Journal of Cystic Fibrosis.  20 (2021)  - p. S203-S204 , 2021
 
?
 
?
12

213: Impact of nitrogen-bisphosphonate on vitamin E and D s..:

Lee, K. ; Su, V. ; Quon, B....
Journal of Cystic Fibrosis.  20 (2021)  - p. S104 , 2021
 
?
13

154: Characterizing pulmonary exacerbation inflammatory phe..:

Dong, K. ; Huh, S. ; Lam, G....
Journal of Cystic Fibrosis.  20 (2021)  - p. S77 , 2021
 
?
14

546: Correlation between systemic inflammatory biomarkers a..:

Gill, E. ; Dong, K. ; Zuniga, J..
Journal of Cystic Fibrosis.  20 (2021)  - p. S258 , 2021
 
?
15

533: Whole-blood transcriptome biomarkers of pulmonary exac..:

Dong, K. ; Chen, V. ; Shannon, C....
Journal of Cystic Fibrosis.  20 (2021)  - p. S251-S252 , 2021
 
1-15